This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical: Archive
Roche Antiviral Drug Reduces Transmission in Late-stage Study
by Zacks Equity Research
Results from a late-stage study on RHHBY's Xofluza show that the drug reduces the transmission of influenza from an infected person to household members.
RHHBYPositive Net Change PFENegative Net Change LLYNegative Net Change BAYRYNegative Net Change
biotechnology medical pharmaceuticals
Do Options Traders Know Something About Enhabit (EHAB) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Enhabit (EHAB) stock based on the movements in the options market lately.
EHABPositive Net Change
medical
New Strong Sell Stocks for September 20th
by Zacks Equity Research
AMKR, BW and AMFPF have been added to the Zacks Rank #5 (Strong Sell) List on September 20 2024.
AMKRPositive Net Change BWPositive Net Change AMFPFNo Net Change
computers medical semiconductor
Implied Volatility Surging for Tactile Systems (TCMD) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Tactile Systems (TCMD) stock based on the movements in the options market lately.
TCMDPositive Net Change
medical medical-devices
BiomX Stock Gains From Favorable Study Data Presentation on BX004
by Zacks Equity Research
PHGE is set to present data from its Phase 1b/2a study for BX004 at the North American Cystic Fibrosis Conference in Boston on Sept. 27 and Sept. 28.
AXGNNegative Net Change KIDSNegative Net Change TMDXNegative Net Change PHGEPositive Net Change
medical
4 Stocks to Buy Amid Dental Supplies Industry Challenges
by Indrajit Bandyopadhyay
Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These include BDX, MCK, COO and STAA.
BDXPositive Net Change MCKNegative Net Change COONegative Net Change STAANegative Net Change
medical medical-devices
Innovation Aids Alcon Stock's Growth Despite Macroeconomic Troubles
by Zacks Equity Research
Banking on strong sales of its contact lenses and ocular health products, ALC is registering solid growth within Vision Care.
BSXPositive Net Change ALCPositive Net Change AXGNNegative Net Change PAHCNegative Net Change
medical medical-devices
DGX Stock to Benefit From New Partnership With Sentara Health Plans
by Zacks Equity Research
Quest Diagnostics extends services in Virginia and Florida via a partnership with Sentara Health Plans.
BSXPositive Net Change DGXPositive Net Change AXGNNegative Net Change PAHCNegative Net Change
medical medical-devices
New Strong Buy Stocks for September 20th
by Zacks Equity Research
QFIN, CLCO, HCA, STRL and CSGS have been added to the Zacks Rank #1 (Strong Buy) List on September 20, 2024.
HCAPositive Net Change CSGSNegative Net Change STRLPositive Net Change QFINPositive Net Change CLCONo Net Change
business-services computers construction medical transportation
Company News for Sep 20, 2024
by Zacks Equity Research
Companies In The News Are: PGNY, EWTX, FDS, SCS.
FDSPositive Net Change SCSPositive Net Change PGNYPositive Net Change EWTXNegative Net Change
biotechnology business-services medical
Universal Health Up 23% in 3 Months: Time to Buy or Miss the Boat?
by Debasmita Chatterjee
UHS witnesses revenue growth from increased patient volumes and strategic initiatives. An extensive treatment network remains an added strength.
UHSPositive Net Change THCPositive Net Change HCAPositive Net Change
medical
GSK Meets Study Goal for Co-Administered RSV-Shingles Vaccines
by Zacks Equity Research
Data from a late-stage study shows that co-administering GSK's RSV and Shingles vaccines together was as effective as giving each separately.
GSKPositive Net Change ILMNNegative Net Change KRYSNegative Net Change BVSNegative Net Change
biotechs medical pharmaceuticals vaccines
Bioventus Surges 103% in Six Months: Is the Stock Worth a Buy?
by Sundeep Ganoria
BVS' stock generates phenomenal returns, driven by double-digit revenue growth across the Pain Treatments and Surgical Solutions franchises.
JNJNegative Net Change MDTPositive Net Change BVSNegative Net Change
biotechs medical
Molina Healthcare Stock Rises 15.4% in 3 Months: Should You Buy?
by Zacks Equity Research
MOH stock is expected to benefit from contract wins, rising premiums and expansion initiatives.
MOHNegative Net Change LMATPositive Net Change ENSGPositive Net Change AVNSNegative Net Change
medical
Here's Why You Should Retain McKesson Stock in Your Portfolio Now
by Zacks Equity Research
MCK's strategic collaborations and strength in Biologics raise optimism about the stock.
DGXPositive Net Change UHSPositive Net Change MCKNegative Net Change ABMNegative Net Change
medical medical-devices
GEHC Stock Rises as FDA Clears MIM Software's Centiloid Tool
by Zacks Equity Research
GE Healthcare's MIM Software announces the receipt of FDA clearance for its Centiloid scaling tool to perform PET-based amyloid imaging.
DGXPositive Net Change UHSPositive Net Change ABMNegative Net Change GEHCPositive Net Change
medical medical-devices
EWTX Stock Soars on Upbeat Efficacy Data From Cardiomyopathy Studies
by Zacks Equity Research
Edgewise stock soars on positive data from an early-stage study and Part A of a mid-stage study of EDG-7500 in obstructive hypertrophic cardiomyopathy patients.
ILMNNegative Net Change KRYSNegative Net Change FULCNegative Net Change EWTXNegative Net Change
biotechnology biotechs medical pharmaceuticals
APLT Stock Soars 69% on Positive Update on Galactosemia Drug NDA
by Zacks Equity Research
Applied Therapeutics stock surges 69% as the FDA says that no advisory committee meeting is required to discuss the govorestat NDA for classic galactosemia.
ILMNNegative Net Change KRYSNegative Net Change APLTNegative Net Change FULCNegative Net Change
biotechnology biotechs medical pharmaceuticals
VERO Stock Likely to Get Support From New Regulatory Nod in Australia
by Zacks Equity Research
The latest approval for Venus Concept in Australia reinforces its position as a global player in the aesthetic technology space.
AXGNNegative Net Change KIDSNegative Net Change TMDXNegative Net Change VERONegative Net Change
medical medical-devices
BD Stock Rises as Neopak XtraFlow Syringe Expands in Biologics
by Zacks Equity Research
BDX launches the Neopak XtraFlow Glass Prefillable Syringe, enhancing drug delivery for biologics and expanding capacity with new high-volume production lines.
BDXPositive Net Change UHSPositive Net Change AVAHNegative Net Change ATIPNegative Net Change
medical medical-devices
MMSI Stock Likely to Gain From Cook Medical's Product Portfolio Buyout
by Zacks Equity Research
Merit Medical expects to solidify its foothold in the underpenetrated global lead management market via the latest asset acquisition.
BSXPositive Net Change BAXPositive Net Change DVANegative Net Change MMSIPositive Net Change
medical medical-devices
Abbott Stock Hurt by Macroeconomic Issues & FX Headwind
by Zacks Equity Research
Foreign exchange fluctuation is a major headwind for ABT, as a considerable percentage of its revenues comes from outside the United States.
ABTPositive Net Change AXGNNegative Net Change KIDSNegative Net Change TMDXNegative Net Change
medical medical-devices
Select Medical Rises 50.2% YTD: Take Profits or Bet on More Gains?
by Zacks Equity Research
SEM's profitability is being impacted by rising costs and expenses.
UHSPositive Net Change THCPositive Net Change SEMPositive Net Change CDNANegative Net Change
medical
QGEN Stock Likely to Gain From Newly Launched Assays for QIAcuity
by Zacks Equity Research
QIAGEN launches 100 new assays for QIAcuity. The newly launched assays are now available through the company???s GeneGlobe platform.
QGENNegative Net Change AXGNNegative Net Change KIDSNegative Net Change TMDXNegative Net Change
medical
Here's Why You Should Retain Integer Holdings Stock in Your Portfolio Now
by Zacks Equity Research
ITGR's research and product development activities raise optimism about the stock. Rising demand for its products bodes well for the company.
BSXPositive Net Change BAXPositive Net Change DVANegative Net Change ITGRNegative Net Change
medical medical-devices